A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
NCT04671615
·
clinicaltrials.gov ↗
COMPLETED
Status
559
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
palbociclib
Sponsor
Pfizer